Craig Porter
Concepts (292)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Burns | 31 | 2021 | 170 | 9.160 |
Why?
| Muscle, Skeletal | 30 | 2023 | 847 | 4.220 |
Why?
| Adipose Tissue, Brown | 14 | 2022 | 45 | 4.040 |
Why?
| Mitochondria, Muscle | 9 | 2018 | 46 | 3.870 |
Why?
| Mitochondria | 15 | 2021 | 489 | 3.190 |
Why?
| Thermogenesis | 7 | 2022 | 22 | 2.850 |
Why?
| Adipose Tissue, White | 8 | 2022 | 39 | 2.610 |
Why?
| Energy Metabolism | 13 | 2023 | 311 | 2.560 |
Why?
| Muscle Proteins | 13 | 2021 | 307 | 1.500 |
Why?
| Glucose | 3 | 2023 | 366 | 1.300 |
Why?
| Cachexia | 4 | 2019 | 24 | 1.100 |
Why?
| Exercise Therapy | 6 | 2021 | 123 | 1.100 |
Why?
| Resistance Training | 7 | 2021 | 102 | 1.020 |
Why?
| Oxygen Consumption | 6 | 2018 | 223 | 0.980 |
Why?
| Muscle Fibers, Skeletal | 3 | 2019 | 78 | 0.970 |
Why?
| Physical Conditioning, Animal | 2 | 2023 | 58 | 0.960 |
Why?
| Proteomics | 2 | 2023 | 343 | 0.900 |
Why?
| Adipocytes | 2 | 2021 | 129 | 0.880 |
Why?
| Lipid Metabolism | 5 | 2019 | 194 | 0.840 |
Why?
| Insulin Resistance | 5 | 2019 | 300 | 0.830 |
Why?
| Peripheral Arterial Disease | 1 | 2023 | 88 | 0.810 |
Why?
| Muscular Atrophy | 3 | 2021 | 73 | 0.810 |
Why?
| Cell Respiration | 6 | 2019 | 51 | 0.750 |
Why?
| Mice, Inbred BALB C | 6 | 2020 | 368 | 0.750 |
Why?
| Quadriceps Muscle | 4 | 2021 | 49 | 0.740 |
Why?
| Humans | 56 | 2023 | 54246 | 0.700 |
Why?
| Male | 39 | 2022 | 27312 | 0.690 |
Why?
| Diabetes Mellitus | 1 | 2023 | 307 | 0.680 |
Why?
| Sepsis | 2 | 2019 | 251 | 0.660 |
Why?
| Mitochondria, Liver | 2 | 2018 | 86 | 0.660 |
Why?
| Musculoskeletal Diseases | 1 | 2018 | 40 | 0.660 |
Why?
| Animals | 19 | 2023 | 14385 | 0.650 |
Why?
| Mitochondrial Proteins | 6 | 2017 | 121 | 0.650 |
Why?
| Stress, Physiological | 2 | 2016 | 194 | 0.650 |
Why?
| Oxidative Phosphorylation | 2 | 2015 | 57 | 0.640 |
Why?
| Down-Regulation | 2 | 2017 | 388 | 0.610 |
Why?
| Sex Characteristics | 1 | 2018 | 214 | 0.580 |
Why?
| Mitochondrial Diseases | 2 | 2015 | 109 | 0.560 |
Why?
| Oxidative Stress | 3 | 2018 | 958 | 0.540 |
Why?
| Electron Transport Complex II | 1 | 2015 | 11 | 0.530 |
Why?
| Electron Transport Complex I | 1 | 2015 | 42 | 0.520 |
Why?
| Ion Channels | 4 | 2015 | 75 | 0.490 |
Why?
| Muscle Strength | 7 | 2021 | 132 | 0.460 |
Why?
| Mice | 10 | 2022 | 6413 | 0.440 |
Why?
| Amino Acids | 2 | 2020 | 369 | 0.430 |
Why?
| Quality of Life | 1 | 2018 | 922 | 0.420 |
Why?
| Young Adult | 10 | 2021 | 4308 | 0.390 |
Why?
| Fungal Proteins | 3 | 2020 | 134 | 0.390 |
Why?
| Recovery of Function | 3 | 2021 | 222 | 0.390 |
Why?
| Health Status | 1 | 2013 | 368 | 0.380 |
Why?
| Aging | 2 | 2017 | 784 | 0.370 |
Why?
| Fibroblast Growth Factors | 2 | 2021 | 59 | 0.360 |
Why?
| Female | 25 | 2022 | 28418 | 0.360 |
Why?
| Blood Glucose | 4 | 2017 | 488 | 0.360 |
Why?
| Muscular Diseases | 2 | 2020 | 65 | 0.350 |
Why?
| Citrate (si)-Synthase | 3 | 2019 | 12 | 0.340 |
Why?
| Adult | 12 | 2023 | 14182 | 0.330 |
Why?
| Cold Temperature | 4 | 2017 | 53 | 0.330 |
Why?
| Subcutaneous Fat | 2 | 2019 | 19 | 0.320 |
Why?
| Basal Metabolism | 3 | 2018 | 36 | 0.320 |
Why?
| Child | 14 | 2022 | 7337 | 0.310 |
Why?
| Case-Control Studies | 5 | 2017 | 1228 | 0.290 |
Why?
| Child, Preschool | 6 | 2018 | 4146 | 0.270 |
Why?
| Adolescent | 10 | 2018 | 6885 | 0.260 |
Why?
| Lipids | 2 | 2023 | 178 | 0.250 |
Why?
| Exercise | 5 | 2021 | 548 | 0.250 |
Why?
| Rats | 2 | 2023 | 3415 | 0.240 |
Why?
| Body Composition | 5 | 2021 | 349 | 0.240 |
Why?
| Beverages | 2 | 2021 | 83 | 0.240 |
Why?
| Limb Salvage | 1 | 2023 | 40 | 0.230 |
Why?
| Liver | 4 | 2023 | 1225 | 0.230 |
Why?
| Protein Biosynthesis | 3 | 2021 | 273 | 0.220 |
Why?
| Regeneration | 2 | 2020 | 72 | 0.220 |
Why?
| Pregnancy in Diabetics | 1 | 2022 | 25 | 0.210 |
Why?
| RNA, Messenger | 2 | 2016 | 1202 | 0.210 |
Why?
| Ischemia | 1 | 2023 | 177 | 0.210 |
Why?
| Trauma Severity Indices | 2 | 2019 | 57 | 0.210 |
Why?
| Cardiomyopathy, Hypertrophic | 1 | 2022 | 38 | 0.210 |
Why?
| Proteolysis | 2 | 2019 | 102 | 0.200 |
Why?
| Diabetes, Gestational | 1 | 2022 | 54 | 0.200 |
Why?
| Catecholamines | 1 | 2021 | 48 | 0.200 |
Why?
| Body Mass Index | 4 | 2018 | 712 | 0.200 |
Why?
| Oxandrolone | 2 | 2018 | 10 | 0.200 |
Why?
| Time Factors | 4 | 2017 | 3212 | 0.190 |
Why?
| Bed Rest | 1 | 2021 | 39 | 0.190 |
Why?
| Diet, High-Fat | 2 | 2019 | 216 | 0.190 |
Why?
| Adiposity | 3 | 2019 | 142 | 0.190 |
Why?
| Propranolol | 2 | 2018 | 78 | 0.190 |
Why?
| Phenylalanine | 1 | 2020 | 125 | 0.180 |
Why?
| Myofibrils | 2 | 2020 | 21 | 0.180 |
Why?
| Hepatocytes | 2 | 2019 | 214 | 0.180 |
Why?
| Carnitine | 2 | 2019 | 86 | 0.180 |
Why?
| Milk Proteins | 1 | 2020 | 76 | 0.180 |
Why?
| Apoptosis | 2 | 2016 | 1300 | 0.180 |
Why?
| Capillaries | 1 | 2019 | 58 | 0.180 |
Why?
| Metformin | 2 | 2017 | 66 | 0.180 |
Why?
| Gonads | 1 | 2019 | 3 | 0.170 |
Why?
| Leukocytes, Mononuclear | 1 | 2019 | 133 | 0.170 |
Why?
| Signal Transduction | 3 | 2021 | 1753 | 0.170 |
Why?
| Mice, Inbred C57BL | 2 | 2022 | 1999 | 0.170 |
Why?
| Prospective Studies | 4 | 2018 | 2604 | 0.170 |
Why?
| Receptors, Aryl Hydrocarbon | 1 | 2019 | 29 | 0.170 |
Why?
| Inflammation | 2 | 2020 | 674 | 0.170 |
Why?
| GTPase-Activating Proteins | 1 | 2019 | 23 | 0.170 |
Why?
| Adaptation, Physiological | 1 | 2019 | 101 | 0.170 |
Why?
| Adrenergic beta-Antagonists | 2 | 2021 | 105 | 0.170 |
Why?
| Obesity | 3 | 2019 | 1197 | 0.170 |
Why?
| Sarcopenia | 1 | 2019 | 83 | 0.170 |
Why?
| Up-Regulation | 2 | 2017 | 508 | 0.160 |
Why?
| Middle Aged | 8 | 2019 | 13070 | 0.160 |
Why?
| Hep G2 Cells | 1 | 2018 | 46 | 0.160 |
Why?
| Electron Transport | 1 | 2018 | 35 | 0.160 |
Why?
| Weight Gain | 1 | 2019 | 243 | 0.160 |
Why?
| National Institute of General Medical Sciences (U.S.) | 1 | 2017 | 1 | 0.160 |
Why?
| Cystathionine beta-Synthase | 1 | 2017 | 13 | 0.160 |
Why?
| T-Lymphocyte Subsets | 1 | 2017 | 41 | 0.160 |
Why?
| Immunologic Memory | 1 | 2017 | 32 | 0.160 |
Why?
| Superoxides | 1 | 2018 | 61 | 0.160 |
Why?
| Adenomatous Polyps | 1 | 2017 | 9 | 0.160 |
Why?
| Chagas Disease | 1 | 2017 | 4 | 0.160 |
Why?
| Appetite Regulation | 1 | 2017 | 14 | 0.150 |
Why?
| Burns, Electric | 1 | 2017 | 2 | 0.150 |
Why?
| Multiple Organ Failure | 1 | 2017 | 56 | 0.150 |
Why?
| Blotting, Western | 2 | 2016 | 683 | 0.150 |
Why?
| Neuropeptides | 1 | 2017 | 48 | 0.150 |
Why?
| Adipocytes, Brown | 1 | 2017 | 10 | 0.150 |
Why?
| Membrane Potential, Mitochondrial | 1 | 2017 | 48 | 0.150 |
Why?
| Triglycerides | 1 | 2018 | 195 | 0.150 |
Why?
| Research Support as Topic | 1 | 2017 | 51 | 0.150 |
Why?
| Physical Endurance | 1 | 2017 | 49 | 0.150 |
Why?
| Colon | 1 | 2017 | 110 | 0.150 |
Why?
| NF-E2-Related Factor 2 | 1 | 2017 | 63 | 0.150 |
Why?
| Aged | 7 | 2021 | 10041 | 0.150 |
Why?
| Fatty Acids | 1 | 2017 | 174 | 0.150 |
Why?
| Palmitoylcarnitine | 1 | 2016 | 8 | 0.150 |
Why?
| Chronic Disease | 2 | 2017 | 612 | 0.140 |
Why?
| Ventricular Dysfunction, Left | 1 | 2017 | 98 | 0.140 |
Why?
| Blood Cells | 1 | 2016 | 58 | 0.140 |
Why?
| Satellite Cells, Skeletal Muscle | 1 | 2016 | 23 | 0.140 |
Why?
| Cardiomyopathies | 1 | 2017 | 129 | 0.140 |
Why?
| Gastrointestinal Tract | 1 | 2017 | 135 | 0.140 |
Why?
| Trauma Centers | 1 | 2017 | 218 | 0.140 |
Why?
| Electron Transport Chain Complex Proteins | 1 | 2015 | 13 | 0.140 |
Why?
| Intestinal Mucosa | 1 | 2017 | 259 | 0.140 |
Why?
| Physical Education and Training | 1 | 2015 | 27 | 0.140 |
Why?
| Proton Ionophores | 1 | 2015 | 3 | 0.130 |
Why?
| Neck | 1 | 2016 | 116 | 0.130 |
Why?
| Carbonyl Cyanide m-Chlorophenyl Hydrazone | 1 | 2015 | 5 | 0.130 |
Why?
| Uncoupling Agents | 1 | 2015 | 7 | 0.130 |
Why?
| Infant | 3 | 2022 | 3817 | 0.130 |
Why?
| Oligomycins | 1 | 2015 | 8 | 0.130 |
Why?
| Adipose Tissue | 1 | 2017 | 207 | 0.130 |
Why?
| Reactive Oxygen Species | 1 | 2017 | 491 | 0.130 |
Why?
| Severity of Illness Index | 2 | 2018 | 1084 | 0.130 |
Why?
| Infant, Newborn | 2 | 2022 | 2907 | 0.130 |
Why?
| Cardiovascular System | 1 | 2015 | 50 | 0.130 |
Why?
| Lung | 2 | 2015 | 507 | 0.130 |
Why?
| Anabolic Agents | 1 | 2014 | 35 | 0.120 |
Why?
| Acute Disease | 1 | 2015 | 403 | 0.120 |
Why?
| Androgens | 1 | 2014 | 68 | 0.120 |
Why?
| Biomedical Research | 1 | 2017 | 240 | 0.120 |
Why?
| Insulin | 4 | 2019 | 510 | 0.120 |
Why?
| Rest | 1 | 2014 | 68 | 0.120 |
Why?
| DNA, Mitochondrial | 1 | 2015 | 186 | 0.120 |
Why?
| Risk Factors | 1 | 2023 | 3930 | 0.120 |
Why?
| Rats, Sprague-Dawley | 1 | 2018 | 1663 | 0.120 |
Why?
| Overweight | 1 | 2016 | 239 | 0.120 |
Why?
| Treatment Outcome | 2 | 2023 | 5604 | 0.120 |
Why?
| Cohort Studies | 2 | 2015 | 1543 | 0.120 |
Why?
| Hypoglycemic Agents | 1 | 2014 | 177 | 0.110 |
Why?
| Infusions, Intravenous | 1 | 2013 | 231 | 0.110 |
Why?
| Metabolic Diseases | 1 | 2013 | 43 | 0.110 |
Why?
| Biopsy | 1 | 2014 | 692 | 0.100 |
Why?
| Mice, Knockout | 3 | 2019 | 926 | 0.100 |
Why?
| Fluorodeoxyglucose F18 | 3 | 2017 | 205 | 0.100 |
Why?
| Double-Blind Method | 2 | 2020 | 742 | 0.080 |
Why?
| Dietary Proteins | 2 | 2021 | 229 | 0.080 |
Why?
| Aged, 80 and over | 1 | 2015 | 3429 | 0.080 |
Why?
| Torque | 2 | 2018 | 24 | 0.070 |
Why?
| Mitochondria, Heart | 2 | 2017 | 42 | 0.070 |
Why?
| Mice, Transgenic | 2 | 2019 | 656 | 0.070 |
Why?
| Gene Expression | 2 | 2020 | 664 | 0.070 |
Why?
| Homeostasis | 2 | 2019 | 223 | 0.070 |
Why?
| Body Surface Area | 2 | 2016 | 25 | 0.070 |
Why?
| Kinetics | 2 | 2018 | 692 | 0.070 |
Why?
| Nutritional Support | 2 | 2015 | 35 | 0.070 |
Why?
| Exercise Test | 2 | 2017 | 151 | 0.070 |
Why?
| Oxidation-Reduction | 2 | 2016 | 382 | 0.060 |
Why?
| Radiopharmaceuticals | 2 | 2017 | 238 | 0.060 |
Why?
| Phenotype | 2 | 2019 | 820 | 0.060 |
Why?
| Gene Expression Regulation | 2 | 2020 | 1062 | 0.060 |
Why?
| Positron-Emission Tomography | 2 | 2017 | 322 | 0.060 |
Why?
| Polyphenols | 1 | 2021 | 55 | 0.050 |
Why?
| Muscle Contraction | 1 | 2021 | 109 | 0.050 |
Why?
| Disease Models, Animal | 2 | 2017 | 1639 | 0.050 |
Why?
| Leucine | 1 | 2021 | 113 | 0.050 |
Why?
| Protein Processing, Post-Translational | 1 | 2021 | 183 | 0.050 |
Why?
| Nutritional Physiological Phenomena | 1 | 2019 | 22 | 0.050 |
Why?
| Tomography, X-Ray Computed | 2 | 2017 | 1213 | 0.040 |
Why?
| Hypertrophy | 1 | 2019 | 52 | 0.040 |
Why?
| Body Temperature Regulation | 1 | 2019 | 35 | 0.040 |
Why?
| Mothers | 1 | 2022 | 247 | 0.040 |
Why?
| NF-kappa B | 1 | 2021 | 335 | 0.040 |
Why?
| Ubiquitin-Protein Ligases | 1 | 2019 | 99 | 0.040 |
Why?
| Rabbits | 1 | 2019 | 425 | 0.040 |
Why?
| Tamoxifen | 1 | 2019 | 60 | 0.040 |
Why?
| Drinking | 1 | 2019 | 78 | 0.040 |
Why?
| HEK293 Cells | 1 | 2019 | 245 | 0.040 |
Why?
| Acetyl-CoA Carboxylase | 1 | 2017 | 17 | 0.040 |
Why?
| Adoptive Transfer | 1 | 2017 | 38 | 0.040 |
Why?
| Host-Parasite Interactions | 1 | 2017 | 20 | 0.040 |
Why?
| Artifacts | 1 | 2018 | 61 | 0.040 |
Why?
| Retrospective Studies | 2 | 2022 | 6432 | 0.040 |
Why?
| HCT116 Cells | 1 | 2017 | 27 | 0.040 |
Why?
| Antioxidant Response Elements | 1 | 2017 | 3 | 0.040 |
Why?
| Autophagy | 1 | 2019 | 202 | 0.040 |
Why?
| Gastric Inhibitory Polypeptide | 1 | 2017 | 1 | 0.040 |
Why?
| Exercise Tolerance | 1 | 2017 | 48 | 0.040 |
Why?
| Athletic Injuries | 1 | 2020 | 225 | 0.040 |
Why?
| Transplantation, Heterologous | 1 | 2017 | 77 | 0.040 |
Why?
| Glucagon | 1 | 2017 | 34 | 0.040 |
Why?
| Hydrogen Sulfide | 1 | 2017 | 14 | 0.040 |
Why?
| History, 21st Century | 1 | 2017 | 62 | 0.040 |
Why?
| Ghrelin | 1 | 2017 | 35 | 0.040 |
Why?
| Malaria | 1 | 2017 | 37 | 0.040 |
Why?
| Transcription, Genetic | 1 | 2019 | 418 | 0.040 |
Why?
| History, 20th Century | 1 | 2017 | 114 | 0.040 |
Why?
| Lymphocyte Activation | 1 | 2017 | 197 | 0.040 |
Why?
| Feeding Behavior | 1 | 2019 | 199 | 0.040 |
Why?
| Mice, Nude | 1 | 2017 | 283 | 0.040 |
Why?
| Child, Hospitalized | 1 | 2017 | 34 | 0.040 |
Why?
| Superoxide Dismutase | 1 | 2017 | 125 | 0.040 |
Why?
| Drug Administration Schedule | 1 | 2017 | 401 | 0.040 |
Why?
| Endopeptidase Clp | 1 | 2016 | 1 | 0.040 |
Why?
| Protein Binding | 1 | 2019 | 736 | 0.040 |
Why?
| PAX7 Transcription Factor | 1 | 2016 | 11 | 0.040 |
Why?
| ATP-Dependent Proteases | 1 | 2016 | 2 | 0.040 |
Why?
| MyoD Protein | 1 | 2016 | 11 | 0.040 |
Why?
| Palmitates | 1 | 2016 | 28 | 0.040 |
Why?
| Mitochondrial Membrane Transport Proteins | 1 | 2016 | 23 | 0.040 |
Why?
| Myosin Heavy Chains | 1 | 2016 | 19 | 0.040 |
Why?
| Hyperinsulinism | 1 | 2016 | 27 | 0.040 |
Why?
| Metabolism | 1 | 2016 | 28 | 0.040 |
Why?
| HeLa Cells | 1 | 2017 | 291 | 0.040 |
Why?
| Body Weight | 1 | 2019 | 578 | 0.040 |
Why?
| Cell Movement | 1 | 2017 | 271 | 0.040 |
Why?
| Multiprotein Complexes | 1 | 2016 | 30 | 0.040 |
Why?
| Metabolomics | 1 | 2017 | 149 | 0.040 |
Why?
| Promoter Regions, Genetic | 1 | 2019 | 520 | 0.040 |
Why?
| Lipoproteins | 1 | 2016 | 45 | 0.040 |
Why?
| Caspase 3 | 1 | 2016 | 135 | 0.040 |
Why?
| CD4-Positive T-Lymphocytes | 1 | 2017 | 180 | 0.040 |
Why?
| Peroxidase | 1 | 2015 | 19 | 0.030 |
Why?
| Heart Rate | 1 | 2018 | 357 | 0.030 |
Why?
| Microscopy, Electron | 1 | 2016 | 97 | 0.030 |
Why?
| TOR Serine-Threonine Kinases | 1 | 2016 | 85 | 0.030 |
Why?
| Leptin | 1 | 2017 | 154 | 0.030 |
Why?
| Neutrophil Infiltration | 1 | 2015 | 29 | 0.030 |
Why?
| Fluorescent Antibody Technique | 1 | 2016 | 141 | 0.030 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2016 | 206 | 0.030 |
Why?
| Cell Survival | 1 | 2017 | 657 | 0.030 |
Why?
| Sex Factors | 1 | 2018 | 765 | 0.030 |
Why?
| Proteasome Endopeptidase Complex | 1 | 2016 | 131 | 0.030 |
Why?
| Linear Models | 1 | 2016 | 309 | 0.030 |
Why?
| Lipid Peroxidation | 1 | 2015 | 132 | 0.030 |
Why?
| Antioxidants | 1 | 2017 | 297 | 0.030 |
Why?
| Muscle Strength Dynamometer | 1 | 2014 | 12 | 0.030 |
Why?
| Glucose Clamp Technique | 1 | 2014 | 19 | 0.030 |
Why?
| Calorimetry, Indirect | 1 | 2014 | 29 | 0.030 |
Why?
| Cells, Cultured | 1 | 2019 | 1737 | 0.030 |
Why?
| Collagen | 1 | 2016 | 223 | 0.030 |
Why?
| Human Growth Hormone | 1 | 2014 | 51 | 0.030 |
Why?
| Survivors | 1 | 2015 | 137 | 0.030 |
Why?
| Pregnancy | 1 | 2022 | 2620 | 0.030 |
Why?
| Multivariate Analysis | 1 | 2016 | 643 | 0.030 |
Why?
| Cell Line | 1 | 2017 | 1153 | 0.030 |
Why?
| Testosterone | 1 | 2014 | 119 | 0.030 |
Why?
| Organ Size | 1 | 2014 | 237 | 0.030 |
Why?
| Absorptiometry, Photon | 1 | 2014 | 174 | 0.030 |
Why?
| DNA Damage | 1 | 2015 | 357 | 0.030 |
Why?
| Gene Expression Regulation, Neoplastic | 1 | 2017 | 866 | 0.030 |
Why?
| Recombinant Proteins | 1 | 2014 | 569 | 0.030 |
Why?
| Immunohistochemistry | 1 | 2016 | 1089 | 0.030 |
Why?
| Myocardium | 1 | 2015 | 441 | 0.030 |
Why?
| Ambulatory Care | 1 | 2014 | 229 | 0.030 |
Why?
| Macrophages | 1 | 2015 | 405 | 0.030 |
Why?
| Cytokines | 1 | 2016 | 676 | 0.030 |
Why?
| Gene Expression Profiling | 1 | 2017 | 1138 | 0.030 |
Why?
| Predictive Value of Tests | 1 | 2015 | 1048 | 0.030 |
Why?
| Diabetes Mellitus, Type 2 | 1 | 2016 | 481 | 0.020 |
Why?
| Follow-Up Studies | 1 | 2015 | 2387 | 0.020 |
Why?
| United States | 1 | 2017 | 5200 | 0.020 |
Why?
|
|
Porter's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|